Education
About Us
Working with TipRanks
Follow Us
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
MDMA Stock Chart & Stats
C$0.12
-C$0.03(-8.33%)
At close: 4:00 PM EST
C$0.12
-C$0.03(-8.33%)
Day’s Range― - ―
52-Week RangeC$0.09 - C$0.33
Previous CloseN/A
Volume63.47K
Average Volume (3M)208.17K
Market Cap
C$10.57M
Enterprise ValueC$9.28M
Total Cash (Recent Filing)C$1.25M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Dec 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding105,682,710
10 Day Avg. Volume94,242
30 Day Avg. Volume208,173
Financial Highlights & Ratios
PEG Ratio-8.41
Price to Book (P/B)3.80
Price to Sales (P/S)7.27
P/FCF Ratio-13.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PharmAla Biotech Holdings, Inc. News
MDMA FAQ
What was PharmAla Biotech Holdings, Inc.’s price range in the past 12 months?
PharmAla Biotech Holdings, Inc. lowest stock price was C$0.09 and its highest was C$0.33 in the past 12 months.
What is PharmAla Biotech Holdings, Inc.’s market cap?
PharmAla Biotech Holdings, Inc.’s market cap is C$10.57M.
When is PharmAla Biotech Holdings, Inc.’s upcoming earnings report date?
PharmAla Biotech Holdings, Inc.’s upcoming earnings report date is Dec 19, 2025 which is in 6 days.
How were PharmAla Biotech Holdings, Inc.’s earnings last quarter?
PharmAla Biotech Holdings, Inc. released its earnings results on Jul 25, 2025. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is PharmAla Biotech Holdings, Inc. overvalued?
According to Wall Street analysts PharmAla Biotech Holdings, Inc.’s price is currently Overvalued.
Does PharmAla Biotech Holdings, Inc. pay dividends?
PharmAla Biotech Holdings, Inc. does not currently pay dividends.
What is PharmAla Biotech Holdings, Inc.’s EPS estimate?
PharmAla Biotech Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PharmAla Biotech Holdings, Inc. have?
PharmAla Biotech Holdings, Inc. has 105,682,710 shares outstanding.
What happened to PharmAla Biotech Holdings, Inc.’s price movement after its last earnings report?
PharmAla Biotech Holdings, Inc. reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PharmAla Biotech Holdings, Inc.?
Currently, no hedge funds are holding shares in TSE:MDMA
Company Description
PharmAla Biotech Holdings, Inc.
PharmAla Biotech Holdings, Inc. (MDMA) is a biotechnology company focused on the research, development, and commercialization of pharmaceutical products utilizing psychedelic compounds. The company primarily operates within the pharmaceutical and healthcare sectors, aiming to create innovative treatments for mental health disorders. PharmAla Biotech is committed to the ethical and sustainable development of MDMA-based therapeutics, leveraging cutting-edge scientific advancements to address unmet medical needs.
Technical Analysis
Wesana Health Holdings Inc
―
HAVN Life Sciences
―
Marvel Biosciences Corp
―
Lexston Life Sciences Corp.
―
Lophos Holdings, Inc.
―
Options Prices
Currently, No data available
---